Neuroone Medical Technologies Corp (NMTC)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $6.78M
Last updated: Nov 17, 2026 at 11:00 AM ET
Neuroone Medical Technologies Corp (NMTC) Stock Forecast
Analysts expect Neuroone Medical Technologies (NMTC) to earn -$0.63 per share in the fiscal year ending Sep 30, 2027, on revenue of $12.83M. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Sep 30, 2027 were revised up and 3 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 33.3% |
| Buy | 2 | 66.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
- Fiscal year ending Sep 30, 2027
- -$0.63
- EPS consensus, revenue $12.83M
- Next report
- Dec 15, 2026
- Confirmed, after the close
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Sep 30, 2027 | -$0.63 | -$0.78 to -$0.41 | 3 | $12.83M | $11.00M to $14.49M | 3 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.17 | -$0.22 to -$0.14 | 3 | $3.07M | $3.05M to $3.10M | 2 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 5 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Sep 30, 2027 | 0 | 3 |
| Quarter ending Dec 31, 2026 | 0 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Sep 30, 2027 has worsened from -$0.51.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Sep 30, 2027 | -$0.63 | -$0.63 | -$0.63 | -$0.51 | -$0.51 | N/A |
| Quarter ending Dec 31, 2026 | -$0.17 | -$0.17 | -$0.17 | -$0.15 | -$0.15 | N/A |
Frequently Asked Questions About NMTC
What is the NMTC stock forecast?
Consensus analyst estimates put Neuroone Medical Technologies's EPS at -$0.63 for the fiscal year ending Sep 30, 2027, on revenue of $12.83M. The consensus rating from 3 analysts is Buy.
How do analysts rate NMTC stock?
Of 3 analysts covering Neuroone Medical Technologies, 1 rates it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from NMTC next year?
For the fiscal year ending Sep 30, 2027, the consensus EPS estimate is -$0.63, with estimates from -$0.78 to -$0.41 from 3 analysts.
What revenue do analysts expect from Neuroone Medical Technologies next year?
For the fiscal year ending Sep 30, 2027, the consensus revenue estimate is $12.83M, with estimates from $11.00M to $14.49M.
How many analysts cover NMTC?
3 analysts rate Neuroone Medical Technologies stock, and 3 analysts estimate its EPS for the fiscal year ending Sep 30, 2027.
NMTC pages: Overview, Earnings, Forecast, Financials, Competitors